Cycurion, Inc. Warrant financials
$0.0161−50.00%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $15.1M |
| Gross profit | $1.6M |
| Gross margin | 10.7% |
| Operating income | -$23.4M |
| Net income | -$23.7M |
| Net margin | −156.4% |
| Diluted EPS | $-107.12 |
| EBITDA | -$11.5M |
| Operating cash flow | -$12.1M |
| Free cash flow | -$12.5M |
| Diluted shares | 0.2M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $5.3M |
| Short-term investments | $0.00 |
| Total debt | $9.5M |
| Total assets | $33.5M |
| Total liabilities | $17.2M |
| Shareholders' equity | $16.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology